About Julien
- Reorganising the business or driving strategic transformation and organic growth, and
- Buying, selling or separating a business (due diligence, PMI, carve-out, synergies, Day-1 readiness).
Strategic transformation & PMO
- Lead transformation and reorganisation programmes, translating strategy into TOMs, org structures, roadmaps and Day-1 readiness.
- Run PMO in cross-functional setups: scope, plans, critical path, RAID, KPIs, SteerCos and workstream governance.
- Drive change and communication: stakeholder mapping, comms and training with local leaders.
Transactions (DD, PMI & carve-out)
- Deliver financial / commercial / operational DD: performance and growth drivers, pricing/mix, customer and market views.
- Shape PMI: integration blueprint, synergy view, value-capture and tracking.
- Support carve-outs / separations: standalone cost base, operating model, Day-1 and transition plans.
Typical missions & deliverables
- Transformation / PMO lead for re-orgs or strategic programmes; M&A support from DD through PMI / carve-out.
- Project charters, TOM and org designs, implementation roadmaps, KPI / risk dashboards, SteerCo decks and Day-1/100 plans.
How I work
- Learn fast, stay outcome-focused and don’t give up on complex problems.
- Structured, hands-on, strong at coordination and stakeholder management; clear communication with senior leaders and local teams.
- Comfortable in multi-country, regulated and PE-backed environments; known for reliability, follow-through and a get-it-done attitude.
English
Native or bilingual
French
Native or bilingual
Spanish
Fluent
German
Basic
Experience
- BoehringerIngelheim -PMOFreelance Consultant - Project ManagerPHARMACEUTICALS INDUSTRYJune 2024 - October 2025 (1 year and 4 months)Vienna, Austria
Focus areas
Strategic transformation, target operating model design, reorganisation and optimisation, go-to-market plans, strategic commercial initiatives, and change management & communications.Key achievements
- TA / asset-team operating model: Led the PMO for a regional transformation (c. 3,000 FTEs, 14+ countries) from siloed functions to cross-functional TA / asset teams; translated strategy into a target operating model (roles, decision rights, country archetypes) and enabled Day-1 readiness across markets.
- HQ optimisation / restructuring: Designed and implemented process optimisation for the HQ Human Pharma division using activity/process heatmaps, workshops and cost/FTE analysis, delivering ~€1m annual savings and a 4.5 FTE reduction while improving workflow effectiveness.
- Emergency operating model (product-to-patient): Project managed a cross-functional team to co-design a supply chain emergency operating model for product-to-patient delivery, defining end-to-end processes and governance and saving ~€3m annually.
- GTM — Commercial acceleration (diabetes brand): Project managed a GTM acceleration programme across 14+ countries targeting +2% market share; simplified content and messaging, coordinated rollout plans, and launched a “Champions League” competition (~500 MSRs, ~50 DSMs) to boost competitiveness and sales growth.
Key responsibilities
- Lead PMO delivery: build integrated plans and critical path, manage RAID/dependencies and decision logs, and own SteerCo / governance reporting.
- Drive cross-functional, multi-country execution across HQ, regional and local teams, ensuring alignment, handovers and follow-through.
- Translate leadership vision into target operating models and implementation plans (structures, roles, processes, KPIs and ways of working).
- Set up and run governance and change management.
- Monitor progress, outcomes and KPIs.
- PwCManager Strategy & Transaction AdvisoryCONSULTING AND AUDITSJanuary 2020 - May 2024 (4 years and 4 months)Zurich, SwitzerlandManager Strategy & Transaction Advisory Services: Chile (full time) & Switzerland (contractor basis)Advised PE and corporate clients on 10+ engagements across buy-side, sell-side, carve-out and integration projects.
Key achievements
- Performed a synergy assessment quantified c. $1m p.a. recurring revenue and c. $0.5m p.a. cost savings (~4 FTEs), assessing cross-sell opportunities and duplicate back-office roles and shaping the post-merger integration plan.
- Led vendor due diligence for a European electronics distributor (€300m deal value), analyzing 150k+ SKUs across 10+ countries to explain performance and growth drivers (volume, pricing, mix, margins) and identifying 13+ EBITDA adjustments (~€12m) to support normalised earnings for valuation.
- Supported major carve-outs including Sandoz from Novartis (listing readiness) and a power utility separation, preparing standalone financials and cost-base benchmarks to enable Day 1 readiness and business continuity.
- Conducted in-depth market and competitive analysis for a medical equipment company (~$50m deal value) and built a data-driven performance view by product, business line and customer to identify growth opportunities and inform integration priorities for the PE client.
Key responsibilities
- Lead due diligence engagements with small teams (2–5) and multidisciplinary stakeholders.
- Analyse performance and forecasts, normalise earnings, and evaluate standalone P&Ls, carve-out impacts and synergies.
- Build Day 1/100 plans and synergy tracking; support governance cadence and decision-making.
- Deliver market/competitive assessments and business plan reviews with decision-ready output
- EY ParthenonManager in Strategy & Transaction Advisory ServicesCONSULTING AND AUDITSMay 2016 - December 2019 (3 years and 7 months)Sydney, Australia
Strategy & Transaction Advisory Services (senior consultant and Manager) - Sydney
Managed +15 buy and sell-side due diligence engagements, IPO readiness and, separation & integration, commercial insights engagements; led and coached teams (2-5), coordinated multidisciplinary stakeholders across SaaS, retail, and health & wellnessKey achievements
- Co-led buy-side due diligence for Laser Clinics Group (~80 clinics; ~$51m EBITDA), using cohort analysis to assess ramp-up run-rate (Year 3) and delivering buy-side pro forma adjustments; identified ~$1m earnings reduction supporting valuation for PE client.
- Conducted commercial due diligence on a legal information SaaS platform, built recurring revenue and customer bridge analyses and assessed market size/growth, quantifying ~70% price-driven organic growth and worked with management to refine the business plan, forecast model and overall strategy.
- Performed a strategic separation for an outsourcing division (~$40m EBITDA), building a ~$25m standalone cost base through functional headcount/cost review and benchmarking against similar-sized businesses, supporting standalone readiness and Day 1 planning.
- Delivered a synergy assessment for the integration of merged HR/payroll software companies, quantifying c. $8m of synergies (duplicate roles/run-rate savings) and co-designing the integration blueprint and post-close synergy tracking
Recommendations
Be the first to recommend Julien
Help this freelancer shine by sharing your experience working together.
These freelancer profiles also match your criteria
Agatha Frydrych
Backend Java Software Engineer
4.7
(3)
2
Baptiste Duhen
Fullstack developer
4.6
(4)
5
Amed Hamou
Senior Lead Developer
4
(2)
7
Audrey Champion
Web developer
4.3
(3)
4
Education
- Master in FinanceCARLOSIII,MADRID2012Master in Finance
- Bachelor of ManagementUTS Sydney2010Bachelor of Management